Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial
帕博利珠单抗联合立体定向放射治疗治疗程序性细胞死亡蛋白1抑制剂难治性复发或转移性头颈部鳞状细胞癌:一项II期试验
期刊:International Journal of Radiation Oncology Biology Physics
影响因子:6.5
doi:10.1016/j.ijrobp.2025.12.043
So, Jonathan; Droznin, Alexander D; Tiwari, Payal; Chen, Yu-Hui; Chau, Nicole G; Margalit, Danielle N; Tishler, Roy B; Hanna, Glenn J; Mak, Raymond H; Fitzgerald, Kelly J; Sehgal, Kartik; Li, Shuqiang; Gunasti, Lauren; Kim, Emily; Minken, Jacqueline; Baginska, Joanna; Nau, Allison; Diaz, Ilana Gomez; Shim, Bohoon; Janes, John Thomas 3rd; Uppaluri, Ravindra; Haddad, Robert I; Livak, Kenneth J; Schoenfeld, Jonathan D